 | • レポートコード：QFJ1-4339 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、高血圧＆心不全治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（利尿薬、ベータ遮断薬、エース阻害薬、アルファ遮断薬、その他）、用途別市場規模（男性用、女性用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・高血圧＆心不全治療薬の市場動向 ・企業の競争状況、市場シェア ・高血圧＆心不全治療薬の種類別市場規模と予測2016-2027（利尿薬、ベータ遮断薬、エース阻害薬、アルファ遮断薬、その他） ・高血圧＆心不全治療薬の用途別市場規模と予測2016-2027（男性用、女性用） ・高血圧＆心不全治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・高血圧＆心不全治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・高血圧＆心不全治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・高血圧＆心不全治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・高血圧＆心不全治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Menarini Group、Johnson & Johnson、Lupin、Boehringer Ingelheim、Novartis、Merck & Co、AstraZeneca、Pfizer, Inc、Sanofi SA、Dr. Reddy's Laboratories、Daiichi Sankyo Company Limited） ・結論 |
Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to control HTN in CHF.
Market Analysis and Insights: Global Hypertension and Heart Failure Drugs Market
The global Hypertension and Heart Failure Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hypertension and Heart Failure Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hypertension and Heart Failure Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hypertension and Heart Failure Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hypertension and Heart Failure Drugs market.
Global Hypertension and Heart Failure Drugs Scope and Market Size
Hypertension and Heart Failure Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hypertension and Heart Failure Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diuretics
Beta Blockers
Ace Inhibitors
Alpha Blockers
Others
Segment by Application
Men
Women
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Menarini Group
Johnson & Johnson
Lupin
Boehringer Ingelheim
Novartis
Merck & Co
AstraZeneca
Pfizer, Inc
Sanofi SA
Dr. Reddy’s Laboratories
Daiichi Sankyo Company Limited
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diuretics
1.2.3 Beta Blockers
1.2.4 Ace Inhibitors
1.2.5 Alpha Blockers
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hypertension and Heart Failure Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hypertension and Heart Failure Drugs Market Perspective (2016-2027)
2.2 Hypertension and Heart Failure Drugs Growth Trends by Regions
2.2.1 Hypertension and Heart Failure Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hypertension and Heart Failure Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Hypertension and Heart Failure Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Hypertension and Heart Failure Drugs Industry Dynamic
2.3.1 Hypertension and Heart Failure Drugs Market Trends
2.3.2 Hypertension and Heart Failure Drugs Market Drivers
2.3.3 Hypertension and Heart Failure Drugs Market Challenges
2.3.4 Hypertension and Heart Failure Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypertension and Heart Failure Drugs Players by Revenue
3.1.1 Global Top Hypertension and Heart Failure Drugs Players by Revenue (2016-2021)
3.1.2 Global Hypertension and Heart Failure Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Hypertension and Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hypertension and Heart Failure Drugs Revenue
3.4 Global Hypertension and Heart Failure Drugs Market Concentration Ratio
3.4.1 Global Hypertension and Heart Failure Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypertension and Heart Failure Drugs Revenue in 2020
3.5 Hypertension and Heart Failure Drugs Key Players Head office and Area Served
3.6 Key Players Hypertension and Heart Failure Drugs Product Solution and Service
3.7 Date of Enter into Hypertension and Heart Failure Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypertension and Heart Failure Drugs Breakdown Data by Type
4.1 Global Hypertension and Heart Failure Drugs Historic Market Size by Type (2016-2021)
4.2 Global Hypertension and Heart Failure Drugs Forecasted Market Size by Type (2022-2027)
5 Hypertension and Heart Failure Drugs Breakdown Data by Application
5.1 Global Hypertension and Heart Failure Drugs Historic Market Size by Application (2016-2021)
5.2 Global Hypertension and Heart Failure Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hypertension and Heart Failure Drugs Market Size (2016-2027)
6.2 North America Hypertension and Heart Failure Drugs Market Size by Type
6.2.1 North America Hypertension and Heart Failure Drugs Market Size by Type (2016-2021)
6.2.2 North America Hypertension and Heart Failure Drugs Market Size by Type (2022-2027)
6.2.3 North America Hypertension and Heart Failure Drugs Market Size by Type (2016-2027)
6.3 North America Hypertension and Heart Failure Drugs Market Size by Application
6.3.1 North America Hypertension and Heart Failure Drugs Market Size by Application (2016-2021)
6.3.2 North America Hypertension and Heart Failure Drugs Market Size by Application (2022-2027)
6.3.3 North America Hypertension and Heart Failure Drugs Market Size by Application (2016-2027)
6.4 North America Hypertension and Heart Failure Drugs Market Size by Country
6.4.1 North America Hypertension and Heart Failure Drugs Market Size by Country (2016-2021)
6.4.2 North America Hypertension and Heart Failure Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hypertension and Heart Failure Drugs Market Size (2016-2027)
7.2 Europe Hypertension and Heart Failure Drugs Market Size by Type
7.2.1 Europe Hypertension and Heart Failure Drugs Market Size by Type (2016-2021)
7.2.2 Europe Hypertension and Heart Failure Drugs Market Size by Type (2022-2027)
7.2.3 Europe Hypertension and Heart Failure Drugs Market Size by Type (2016-2027)
7.3 Europe Hypertension and Heart Failure Drugs Market Size by Application
7.3.1 Europe Hypertension and Heart Failure Drugs Market Size by Application (2016-2021)
7.3.2 Europe Hypertension and Heart Failure Drugs Market Size by Application (2022-2027)
7.3.3 Europe Hypertension and Heart Failure Drugs Market Size by Application (2016-2027)
7.4 Europe Hypertension and Heart Failure Drugs Market Size by Country
7.4.1 Europe Hypertension and Heart Failure Drugs Market Size by Country (2016-2021)
7.4.2 Europe Hypertension and Heart Failure Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hypertension and Heart Failure Drugs Market Size (2016-2027)
8.2 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Type
8.2.1 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Application
8.3.1 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Region
8.4.1 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hypertension and Heart Failure Drugs Market Size (2016-2027)
9.2 Latin America Hypertension and Heart Failure Drugs Market Size by Type
9.2.1 Latin America Hypertension and Heart Failure Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Hypertension and Heart Failure Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Hypertension and Heart Failure Drugs Market Size by Type (2016-2027)
9.3 Latin America Hypertension and Heart Failure Drugs Market Size by Application
9.3.1 Latin America Hypertension and Heart Failure Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Hypertension and Heart Failure Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Hypertension and Heart Failure Drugs Market Size by Application (2016-2027)
9.4 Latin America Hypertension and Heart Failure Drugs Market Size by Country
9.4.1 Latin America Hypertension and Heart Failure Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Hypertension and Heart Failure Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypertension and Heart Failure Drugs Market Size (2016-2027)
10.2 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Type
10.2.1 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Application
10.3.1 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Country
10.4.1 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Menarini Group
11.1.1 Menarini Group Company Details
11.1.2 Menarini Group Business Overview
11.1.3 Menarini Group Hypertension and Heart Failure Drugs Introduction
11.1.4 Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.1.5 Menarini Group Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Hypertension and Heart Failure Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Lupin
11.3.1 Lupin Company Details
11.3.2 Lupin Business Overview
11.3.3 Lupin Hypertension and Heart Failure Drugs Introduction
11.3.4 Lupin Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.3.5 Lupin Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Hypertension and Heart Failure Drugs Introduction
11.4.4 Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Hypertension and Heart Failure Drugs Introduction
11.5.4 Novartis Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Merck & Co
11.6.1 Merck & Co Company Details
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Hypertension and Heart Failure Drugs Introduction
11.6.4 Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.6.5 Merck & Co Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Hypertension and Heart Failure Drugs Introduction
11.7.4 AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Pfizer, Inc
11.8.1 Pfizer, Inc Company Details
11.8.2 Pfizer, Inc Business Overview
11.8.3 Pfizer, Inc Hypertension and Heart Failure Drugs Introduction
11.8.4 Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.8.5 Pfizer, Inc Recent Development
11.9 Sanofi SA
11.9.1 Sanofi SA Company Details
11.9.2 Sanofi SA Business Overview
11.9.3 Sanofi SA Hypertension and Heart Failure Drugs Introduction
11.9.4 Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.9.5 Sanofi SA Recent Development
11.10 Dr. Reddy’s Laboratories
11.10.1 Dr. Reddy’s Laboratories Company Details
11.10.2 Dr. Reddy’s Laboratories Business Overview
11.10.3 Dr. Reddy’s Laboratories Hypertension and Heart Failure Drugs Introduction
11.10.4 Dr. Reddy’s Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.10.5 Dr. Reddy’s Laboratories Recent Development
11.11 Daiichi Sankyo Company Limited
11.11.1 Daiichi Sankyo Company Limited Company Details
11.11.2 Daiichi Sankyo Company Limited Business Overview
11.11.3 Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Introduction
11.11.4 Daiichi Sankyo Company Limited Revenue in Hypertension and Heart Failure Drugs Business (2016-2021)
11.11.5 Daiichi Sankyo Company Limited Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diuretics
Table 3. Key Players of Beta Blockers
Table 4. Key Players of Ace Inhibitors
Table 5. Key Players of Alpha Blockers
Table 6. Key Players of Others
Table 7. Global Hypertension and Heart Failure Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hypertension and Heart Failure Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hypertension and Heart Failure Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Hypertension and Heart Failure Drugs Market Share by Regions (2016-2021)
Table 11. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Hypertension and Heart Failure Drugs Market Share by Regions (2022-2027)
Table 13. Hypertension and Heart Failure Drugs Market Trends
Table 14. Hypertension and Heart Failure Drugs Market Drivers
Table 15. Hypertension and Heart Failure Drugs Market Challenges
Table 16. Hypertension and Heart Failure Drugs Market Restraints
Table 17. Global Hypertension and Heart Failure Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Hypertension and Heart Failure Drugs Market Share by Players (2016-2021)
Table 19. Global Top Hypertension and Heart Failure Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypertension and Heart Failure Drugs as of 2020)
Table 20. Ranking of Global Top Hypertension and Heart Failure Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Hypertension and Heart Failure Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hypertension and Heart Failure Drugs Product Solution and Service
Table 24. Date of Enter into Hypertension and Heart Failure Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hypertension and Heart Failure Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Hypertension and Heart Failure Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Hypertension and Heart Failure Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Hypertension and Heart Failure Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Hypertension and Heart Failure Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Hypertension and Heart Failure Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Hypertension and Heart Failure Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Hypertension and Heart Failure Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Hypertension and Heart Failure Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Hypertension and Heart Failure Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Hypertension and Heart Failure Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Hypertension and Heart Failure Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Hypertension and Heart Failure Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Hypertension and Heart Failure Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Hypertension and Heart Failure Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Hypertension and Heart Failure Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Hypertension and Heart Failure Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Hypertension and Heart Failure Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Hypertension and Heart Failure Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Hypertension and Heart Failure Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Hypertension and Heart Failure Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Hypertension and Heart Failure Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Hypertension and Heart Failure Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Hypertension and Heart Failure Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Menarini Group Company Details
Table 65. Menarini Group Business Overview
Table 66. Menarini Group Hypertension and Heart Failure Drugs Product
Table 67. Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 68. Menarini Group Recent Development
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Hypertension and Heart Failure Drugs Product
Table 72. Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Lupin Company Details
Table 75. Lupin Business Overview
Table 76. Lupin Hypertension and Heart Failure Drugs Product
Table 77. Lupin Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 78. Lupin Recent Development
Table 79. Boehringer Ingelheim Company Details
Table 80. Boehringer Ingelheim Business Overview
Table 81. Boehringer Ingelheim Hypertension and Heart Failure Drugs Product
Table 82. Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 83. Boehringer Ingelheim Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Hypertension and Heart Failure Drugs Product
Table 87. Novartis Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. Merck & Co Company Details
Table 90. Merck & Co Business Overview
Table 91. Merck & Co Hypertension and Heart Failure Drugs Product
Table 92. Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 93. Merck & Co Recent Development
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Hypertension and Heart Failure Drugs Product
Table 97. AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 98. AstraZeneca Recent Development
Table 99. Pfizer, Inc Company Details
Table 100. Pfizer, Inc Business Overview
Table 101. Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 102. Pfizer, Inc Recent Development
Table 103. Sanofi SA Company Details
Table 104. Sanofi SA Business Overview
Table 105. Sanofi SA Hypertension and Heart Failure Drugs Product
Table 106. Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 107. Sanofi SA Recent Development
Table 108. Dr. Reddy's Laboratories Company Details
Table 109. Dr. Reddy's Laboratories Business Overview
Table 110. Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Product
Table 111. Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 112. Dr. Reddy's Laboratories Recent Development
Table 113. Daiichi Sankyo Company Limited Company Details
Table 114. Daiichi Sankyo Company Limited Business Overview
Table 115. Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Product
Table 116. Daiichi Sankyo Company Limited Revenue in Hypertension and Heart Failure Drugs Business (2016-2021) & (US$ Million)
Table 117. Daiichi Sankyo Company Limited Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypertension and Heart Failure Drugs Market Share by Type: 2020 VS 2027
Figure 2. Diuretics Features
Figure 3. Beta Blockers Features
Figure 4. Ace Inhibitors Features
Figure 5. Alpha Blockers Features
Figure 6. Others Features
Figure 7. Global Hypertension and Heart Failure Drugs Market Share by Application: 2020 VS 2027
Figure 8. Men Case Studies
Figure 9. Women Case Studies
Figure 10. Hypertension and Heart Failure Drugs Report Years Considered
Figure 11. Global Hypertension and Heart Failure Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Hypertension and Heart Failure Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hypertension and Heart Failure Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Hypertension and Heart Failure Drugs Market Share by Regions (2022-2027)
Figure 15. Global Hypertension and Heart Failure Drugs Market Share by Players in 2020
Figure 16. Global Top Hypertension and Heart Failure Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypertension and Heart Failure Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Hypertension and Heart Failure Drugs Revenue in 2020
Figure 18. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Hypertension and Heart Failure Drugs Market Share by Type (2016-2027)
Figure 22. North America Hypertension and Heart Failure Drugs Market Share by Application (2016-2027)
Figure 23. North America Hypertension and Heart Failure Drugs Market Share by Country (2016-2027)
Figure 24. United States Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hypertension and Heart Failure Drugs Market Share by Type (2016-2027)
Figure 28. Europe Hypertension and Heart Failure Drugs Market Share by Application (2016-2027)
Figure 29. Europe Hypertension and Heart Failure Drugs Market Share by Country (2016-2027)
Figure 30. Germany Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hypertension and Heart Failure Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Hypertension and Heart Failure Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Hypertension and Heart Failure Drugs Market Share by Region (2016-2027)
Figure 40. China Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hypertension and Heart Failure Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Hypertension and Heart Failure Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Hypertension and Heart Failure Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hypertension and Heart Failure Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Hypertension and Heart Failure Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Hypertension and Heart Failure Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Hypertension and Heart Failure Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Menarini Group Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 61. Lupin Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 64. Merck & Co Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 66. Pfizer, Inc Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 67. Sanofi SA Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 68. Dr. Reddy's Laboratories Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 69. Daiichi Sankyo Company Limited Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の心不全治療薬市場規模・現状・予測（2021年-2027年） Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually…- 世界の心不全治療市場規模・現状・予測（2021年-2027年） The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people beca…
- 世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Beta-Lactam Drugs Market The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 高血圧薬のグローバル市場調査 2019年 The global High Blood Pressure Drugs (Hypertension) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on High Blood Pressure Drugs (Hypertension) volume and value at global level, regional level and comp…
- 急性心不全(AHF)治療薬のグローバル市場調査 2019年 The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company …